Filing Flows › Globus Medical (GMED) › Q3 2026
Globus Medical (GMED) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Globus Medical (GMED) reported revenue of $764M for the third quarter 2026 (Q3 2026), -0.7% from a year earlier and -3% from the quarter before. Operating margin was 23.2%, net earnings $141M (18.5% of revenue).
Globus Medical, Q3 2026: revenue $764M (-0.7% year over year), operating margin 23.2%, net earnings $141M, operating cash flow $265M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $764M | -3% | -0.7% |
| Operating profit | $178M | -3% | +29% |
| Net earnings | $141M | -7% | +19% |
| Operating cash flow | $265M | +26% | +6% |
| Free cash flow | $225M | — | +5% |
What changed
Revenue was $763.7M in Q3 2026, down 1% year over year and down 3% from the previous quarter. Musculoskeletal Solutions was the largest line at 95% of revenue. Musculoskeletal Solutions lost $12.2M year over year (down 2%), 228% of the total change.
Operating profit was $177.6M, a 23.2% margin (up 5.4 points year over year). Total costs fell 7% while revenue fell 1%. The fastest-growing cost line was Other operating costs (+10%). Net earnings were $141.2M, up 19% year over year. The effective tax rate was 23.0%.
Operating cash flow was $265.2M (up 6% year over year), 188% of net earnings. Non-cash charges added back $70.4M of depreciation and amortization and $11.7M of share-based compensation. Working capital and other items added $41.9M. After purchases of property and equipment ($40.4M), free cash flow as the company reports it was $224.8M.
Questions
What was Globus Medical's revenue in the third quarter 2026?
Globus Medical (GMED) reported revenue of $764M for the third quarter 2026 (Q3 2026), -0.7% from a year earlier and -3% from the quarter before.
Was Globus Medical profitable in the third quarter 2026?
Operating profit was $178M (23.2% of revenue) and net earnings $141M.
Source: Globus Medical 10-Q on SEC EDGAR.